Investor Conference Call on the planned acquisition of Merck’s Consumer Care business and our new Pharma sGC Cooperation
Tuesday, May 6, 2014
Start at approx. 1:00 p.m. CEST (11:00 a.m. UTC)
Bayer has agreed to acquire the consumer care business of U.S. pharmaceutical company Merck & Co., Inc. and to engage in a strategic pharma cooperation in the field of soluble guanylate cyclase (sGC) modulators. On this occasion we hosted a conference call for investors and analysts.